ASCO 2022 Conference Coverage
M

ASCO 2022 on Atezolizumab + Bevacizumab vs Lenvatinib or Sorafenib in Non-Viral Unresectable HCC: An International Study

By ASCO 2022 Conference Coverage FEATURING Margherita Rimini
By ASCO 2022 Conference Coverage FEATURING Margherita Rimini
278 views
August 5, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Recommended

Houston Methodist

Inaugural Houston Methodist Neal Cancer Center GI Oncology Symposium

Fri, Dec 6, 2024
57:44

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

5.1K views

·

1 year ago
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

·

6 months ago
22:55

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON-BTC-…

Insights from 2023 ASCO® Annual Meeting

R. Kim, R. Mehta

3.1K views

·

1 year ago
20:09

ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunot…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

359 views

·

1 month ago
18:21

New

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

287 views

·

2 weeks ago
10:57

Y90 Radioembolization for Locally Advanced HCC

UCLA Health

S. Padia

627 views

·

8 months ago
15:30

Updates in Combination Therapy for HCC

Yale Cancer Center

S. Stein

456 views

·

6 months ago
13:05

New

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

178 views

·

3 weeks ago
25:09

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

363 views

·

4 months ago
26:59

2023 AASLD Guidance for HCC

University of Texas Southwestern Medical Center

A. Singal

812 views

·

1 year ago
16:40

Year in Review: Hepatobiliary Cancers

Moffitt Cancer Center

R. Kim, T. Biachi

604 views

·

10 months ago
09:56

ESMO 2024 Insights: HIMALAYA - 5-Year OS of Tremelimumab + Durvaluma…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

168 views

·

1 month ago
04:39

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet

165 views

·

1 month ago
13:58

ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 & IMbrav…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, T. Biachi

434 views

·

9 months ago
20:07

New

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

221 views

·

2 weeks ago
15:53

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Yale Cancer Center

A. Jaffe

325 views

·

6 months ago
27:48

Current Approach to Frontline Systemic Therapy for Advanced Hepatoce…

Lionel Kankeu Fonkoua

247 views

·

3 months ago
05:40

New

ESMO 2024 Insights: CheckMate 9DW Expanded Analysis - Nivo + Ipi vs.…

2024 ESMO Annual Meeting Insights Hub

H. Karachiwala

126 views

·

3 weeks ago
22:02

ACG 2023 Highlights: HCC Updates - Diagnosis and Management

ACG 2023 Conference Coverage

R. Wong

620 views

·

1 year ago
21:11

Hepatocellular Carcinoma: Current Management Strategies

Stanford Medicine

R. Dhanasekaran

225 views

·

5 months ago
AUTOPLAY